ArticleInterdisciplinary sciences, computational life sciences2026
Pan-cancer Distant Metastasis Prediction Based on Graph Neural Network.
Article in Interdisciplinary sciences, computational life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Distant metastasis (DM) is the primary driver of cancer-related mortality, and its clinical prediction remains challenging due to the lack of robust biomarkers. This study proposes a novel graph representation that effectively identifies discriminative morphological features from histopathological whole slide images (WSIs). By transforming high-resolution WSIs into topological graphs, the proposed method leverages graph neural networks (GNNs) to capture complex spatial dependencies and cellular organizations critical for metastatic progression. The study is evaluated on a large-scale pan-cancer dataset and demonstrates superior performance in distilling shared metastatic patterns across diverse malignancies. Furthermore, the cross-dataset robustness of this representation is validated by training on a specialized nasopharyngeal carcinoma cohort (TJ-NPC) and evaluating on independent public datasets. The results highlight the potential of computational pathology to provide scalable, objective risk stratification, offering a high accuracy tool for personalized clinical intervention.
Indexed as
Identifiers
42113455What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.